A detailed history of Creative Financial Designs Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Creative Financial Designs Inc holds 174 shares of REGN stock, worth $122,121. This represents 0.02% of its overall portfolio holdings.

Number of Shares
174
Previous 178 2.25%
Holding current value
$122,121
Previous $187,000 2.67%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$1024.09 - $1201.76 $4,096 - $4,807
-4 Reduced 2.25%
174 $182,000
Q2 2024

Aug 06, 2024

BUY
$883.2 - $1071.19 $2,649 - $3,213
3 Added 1.71%
178 $187,000
Q1 2024

May 01, 2024

SELL
$902.69 - $993.35 $7,221 - $7,946
-8 Reduced 4.37%
175 $168,000
Q4 2023

Jan 10, 2024

BUY
$775.18 - $881.7 $775 - $881
1 Added 0.55%
183 $160,000
Q2 2023

Jul 26, 2023

SELL
$700.03 - $830.35 $2,800 - $3,321
-4 Reduced 2.15%
182 $130,000
Q1 2023

Apr 25, 2023

SELL
$680.49 - $826.97 $7,485 - $9,096
-11 Reduced 5.58%
186 $152,000
Q3 2022

Nov 01, 2022

BUY
$573.97 - $724.32 $1,721 - $2,172
3 Added 1.55%
197 $136,000
Q2 2022

Aug 01, 2022

SELL
$548.35 - $738.84 $2,741 - $3,694
-5 Reduced 2.51%
194 $115,000
Q1 2022

Apr 15, 2022

SELL
$595.12 - $698.43 $1,190 - $1,396
-2 Reduced 1.0%
199 $139,000
Q4 2021

Jan 26, 2022

BUY
$543.48 - $670.97 $95,652 - $118,090
176 Added 704.0%
201 $127,000
Q1 2021

Apr 19, 2021

BUY
$446.73 - $548.2 $5,360 - $6,578
12 Added 92.31%
25 $12,000
Q4 2020

Jan 08, 2021

BUY
$478.3 - $607.98 $2,391 - $3,039
5 Added 62.5%
13 $6,000
Q3 2020

Oct 06, 2020

BUY
$544.75 - $658.21 $4,358 - $5,265
8 New
8 $4,000
Q1 2018

May 02, 2018

SELL
$315.82 - $393.78 $0 - $0
0 Closed
0 $0
Q4 2017

May 02, 2018

SELL
$358.63 - $469.95 $10,041 - $13,158
-28 Closed
0 $0
Q2 2017

May 02, 2018

SELL
N/A
-36 Reduced 56.25%
28 $14,000
Q1 2017

May 02, 2018

SELL
N/A
-533 Reduced 89.28%
64 $25,000
Q4 2016

Mar 14, 2018

BUY
N/A
597
597 $219,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Creative Financial Designs Inc Portfolio

Follow Creative Financial Designs Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.